Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization
Maxime Taquet(Oxford Health NHS Foundation Trust), Linzy Houchen-Wolloff(American Thoracic Society), Marco Sereno(University of Leicester), Amisha Singapuri(University of Leicester), Alex Horsley(University of Manchester), Annemarie B Docherty(Edinburgh Royal Infirmary), Betty Raman(University of Leicester), Adam Hampshire(UK Dementia Research Institute), Ruth Saunders(University of Leicester), Jennifer K Quint(Imperial College London), Omer Elneima(University of Leicester), Christopher E. Brightling(NIHR Leicester Biomedical Research Centre), Michael Marks(University of London), Paul J. Harrison(King's College London), Hamish McAuley(University of Leicester), James D. Chalmers(University of Dundee), Louise V. Wain(University of Leicester), Rachael A Evans(University of Leicester), John Geddes(University of Oxford), Ewen M. Harrison(NHS Lothian), Olivia C. Leavy(University of Leicester), Naveed Sattar(University of Glasgow), Ling‐Pei Ho(University of Oxford), Nazir Lone(University of Edinburgh), Neil Greening(University of Leicester), Zuzanna Skórniewska(University of Oxford), Parisa Mansoori(MQ: Transforming Mental Health), Aarti Shikotra(University of Leicester), Matthew Richardson(University of Leicester), Victoria Harris(University of Oxford), Krisnah Poinasamy(Asthma UK)
Cited by 96
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k